2-amino-3-aroyl-4,5-alkylthiophenes:: Agonist allosteric enhancers at human A1 adenosine receptors

被引:85
作者
Tranberg, CE
Zickgraf, A
Giunta, BN
Luetjens, H
Figler, H
Murphree, LJ
Falke, R
Fleischer, H
Linden, J
Scammells, PJ
Olsson, RA
机构
[1] Univ S Florida, Dept Internal Med, Suncoast AHA Cardiovasc Res Lab, Tampa, FL 33612 USA
[2] Deakin Univ, Ctr Chiral & Mol Technol, Geelong, Vic 3217, Australia
[3] Univ Virginia, Dept Med Cardiol, Charlottesville, VA USA
[4] Univ Virginia, Dept Mol Physiol, Charlottesville, VA USA
[5] Univ Virginia, Dept Biol Phys, Charlottesville, VA USA
[6] Johannes Gutenberg Univ Mainz, Inst Analyt Chem, D-6500 Mainz, Germany
关键词
D O I
10.1021/jm010081p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
2-Amino-3-benzoylthiophenes are allosteric enhancers (AE) of agonist activity at the A(1) adenosine receptor. The present report describes syntheses and assays of the AE activity at the human A(1)AR (hA(1)AR) of a panel of compounds consisting of nine 2-amino-3-aroylthiophenes (3a-i), eight 2-amino-3-benzoyl-4,5-dimethylthiophenes (12a-h), three 3-aroyl-2-carboxy-4,5-dimethylthiophenes (15a-c), 10 2-amino-3-benzoyl-5,6-dihydro-4H-cyclopenta[b]thiophenes (17a-j), 14 2-amino-3-benzoyl-4,5,6,7-tetrahydrobenzo[b]thiophenes (18a-n), and 15 2-amino-3-benzoyl-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophenes (19a-o). An in vitro assay employing the A(1)AR agonist [I-125]ABA and membranes from CHO-K1 cells stably expressing the hA(1)AR measured, as an index of AE activity, the ability of a candidate AE to stabilize the agonist-A(1)AR-G protein ternary complex. Compounds 3a-i had little or no AE activity, and compounds 12a-h had only modest activity, evidence that AE activity depended absolutely on the presence of at least a methyl group at C-4 and C-5. Compounds 17a-c lacked AE activity, suggesting the 2-amino group is essential. Polymethylene bridges linked thiophene C-4 and C-5 of compounds 17a-j, 18a-n, and 19a-o. AE activity increased with the size of the -(CH2)(n)- bridge, n = 3 < n = 4 < n = 5. The 3-carbethoxy substituents of 17a, 18a, and 19a did not support AE activity, but a 3-aroyl group did. Bulky (or hydrophobic) substituents at the meta and para positions of the 3-benzoyl group and also 3-naphthoyl groups greatly enhanced activity. Thus, the hA(1)AR contains an allosteric binding site able to accommodate 3-aroyl substituents that are bulky and/or hydrophobic but not necessarily planar. A second region in the allosteric binding site interacts constructively with alkyl substituents at thiophene C-4 and/or C-5.
引用
收藏
页码:382 / 389
页数:8
相关论文
共 28 条
[11]   2-AMINO-THIOPHENE AUS METHYLENAKTIVEN NITRILEN CARBONYLVERBINDUNGEN UND SCHWEFEL [J].
GEWALD, K ;
SCHINKE, E ;
BOTTCHER, H .
CHEMISCHE BERICHTE-RECUEIL, 1966, 99 (01) :94-&
[12]   Novel thieno[2,3-d][1,3]oxazin-4-ones as inhibitors of human leukocyte elastase [J].
Gütschow, M ;
Neumann, U .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (10) :1729-1740
[13]   AROMATIC SUBSTITUENT CONSTANTS FOR STRUCTURE-ACTIVITY CORRELATIONS [J].
HANSCH, C ;
LEO, A ;
UNGER, SH ;
KIM, KH ;
NIKAITANI, D ;
LIEN, EJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (11) :1207-1216
[14]  
HUANGMINLON, 1946, J AM CHEM SOC, V68, P2487, DOI DOI 10.1021/JA01216A013
[15]   SYNTHESIS OF BROMOACETYL DERIVATIVES BY USE OF TETRABUTYLAMMONIUM TRIBROMIDE [J].
KAJIGAESHI, S ;
KAKINAMI, T ;
OKAMOTO, T ;
FUJISAKI, S .
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1987, 60 (03) :1159-1160
[16]   SELECTIVE BROMINATION WITH COPPER(2) BROMIDE [J].
KING, LC ;
OSTRUM, GK .
JOURNAL OF ORGANIC CHEMISTRY, 1964, 29 (12) :3459-&
[17]   ALLOSTERIC ENHANCER PD-81,723 ACTS BY NOVEL MECHANISM TO POTENTIATE CARDIAC ACTIONS OF ADENOSINE [J].
KOLLIASBAKER, C ;
RUBLE, J ;
DENNIS, D ;
BRUNS, RF ;
LINDEN, J ;
BELARDINELLI, L .
CIRCULATION RESEARCH, 1994, 75 (06) :961-971
[18]   NOVEL-APPROACH FOR ENHANCING ATRIOVENTRICULAR NODAL CONDUCTION DELAY MEDIATED BY ENDOGENOUS ADENOSINE [J].
KOLLIASBAKER, C ;
XU, J ;
PELLEG, A ;
BELARDINELLI, L .
CIRCULATION RESEARCH, 1994, 75 (06) :972-980
[19]  
KOUROUNAKIS A, 1999, BIOCHEM PHARMACOL, V42, P3629
[20]  
LEUNG E, 1995, N-S ARCH PHARMACOL, V352, P206